The effects of SGLT2 inhibitors on metabolic phenotype and FGF-21 expression from the adipose tissue and the liver are less pronounced in ob/ob mice.
- DOI
- 10.1186/s12902-025-01879-3
- Published
- 2025 Mar 10
- Container
- BMC endocrine disorders
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12902-025-01879-3,
title = {The effects of SGLT2 inhibitors on metabolic phenotype and FGF-21 expression from the adipose tissue and the liver are less pronounced in ob/ob mice.},
author = {Di Vincenzo A and Granzotto M and Crescenzi M and Fioretto P and Vettor R and Rossato M},
year = {2025},
journal = {BMC endocrine disorders},
doi = {10.1186/s12902-025-01879-3},
url = {https://doi.org/10.1186/s12902-025-01879-3}
}RIS
TY - JOUR TI - The effects of SGLT2 inhibitors on metabolic phenotype and FGF-21 expression from the adipose tissue and the liver are less pronounced in ob/ob mice. AU - Di Vincenzo A AU - Granzotto M AU - Crescenzi M AU - Fioretto P AU - Vettor R AU - Rossato M PY - 2025 JO - BMC endocrine disorders DO - 10.1186/s12902-025-01879-3 UR - https://doi.org/10.1186/s12902-025-01879-3 ER -
APA
A, D. V., M, G., M, C., P, F., R, V., & M, R. (2025). The effects of SGLT2 inhibitors on metabolic phenotype and FGF-21 expression from the adipose tissue and the liver are less pronounced in ob/ob mice.. BMC endocrine disorders. https://doi.org/10.1186/s12902-025-01879-3
Source records
- pubmed · retrieved 2026-11-10T11:29:26.537Z